Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Rigshospitalet

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: Private

Established: 1757-03-30

Employees: 10K

Market Cap: -

Website: http://www.rigshospitalet.dk

Clinical Trials

Supplemental Oxygen and Complications After Abdominal Surgery (The PROXI-trial)

Phase 4

Completed

Conditions: Laparotomy

Interventions: Drug: Oxygen

First Posted Date: 2006-08-16

Last Posted Date: 2009-10-16

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 1400

Registration Number: NCT00364741

Locations: 🇩🇰
Aarhus Sygehus, Aarhus, Denmark
🇩🇰
Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
🇩🇰
Copenhagen University Hospital, Amager, Copenhagen, Denmark

and more 11 locations

Prevention of Constipation: Systematic Nursing Interventions to Reduce Postoperative Constipation After Thoracic Surgery

Not Applicable

Completed

Conditions: Postoperative Constipation

First Posted Date: 2006-08-15

Last Posted Date: 2008-07-01

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 58

Registration Number: NCT00364169

Locations: 🇩🇰
Department of Cardiothoracic Surgery, The Heart Center, University hospital Rigshospitalet, Copenhagen, Denmark

Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)

Phase 2

Terminated

Conditions: Hepatocellular Carcinoma

First Posted Date: 2006-07-12

Last Posted Date: 2008-08-26

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 39

Registration Number: NCT00351195

Locations: 🇩🇰
Århus Sygehus, Dept. of Oncology, Århus, Denmark

Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

Phase 1

Completed

Conditions: Cholangiocarcinoma

First Posted Date: 2006-07-11

Last Posted Date: 2008-08-26

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 39

Registration Number: NCT00350961

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰
Vejle Sygehus, Vejle, Denmark

Avastin and Tarceva for Upper Gastrointestinal Cancers

Phase 2

Completed

Conditions: Cholangiocarcinoma
Gallbladder Cancer

Interventions: Drug: Erlotinib and bevacizumab

First Posted Date: 2006-07-11

Last Posted Date: 2009-07-15

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 126

Registration Number: NCT00350753

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰
Odense University Hospital, Odense, Denmark
🇩🇰
Århus Sygehus, Århus, Denmark

Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Drug: Emtricitabine and Tenofovir (Truvada)
Drug: Zidovudine and Lamivudine (Combivir)

First Posted Date: 2006-06-30

Last Posted Date: 2016-02-23

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 566

Registration Number: NCT00346567

Locations: 🇹🇿
Bombo Regional Hospital, Tanga, Tanzania

Cerebral Blood Flow and Metabolism During Hypoxia and Endotoxemia

Not Applicable

Completed

Conditions: Hypoxia
Endotoxemia
Healthy

First Posted Date: 2006-06-01

Last Posted Date: 2008-09-04

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 36

Registration Number: NCT00332267

Locations: 🇩🇰
Center of Inflammation and Metabolism, Rigshospitalet, Copenhagen, Denmark

Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?

Phase 2

Completed

Conditions: Preterm Delivery

Interventions: Drug: Placebo
Drug: Progesterone

First Posted Date: 2006-05-25

Last Posted Date: 2011-07-25

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 677

Registration Number: NCT00329914

Locations: 🇦🇹
Graz University Hospital, Graz, Austria
🇦🇹
Innsbruck University Hospital, Innsbruck, Austria
🇦🇹
Klagenfurt Hospital, Klagenfurt, Austria

and more 14 locations

Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma

Phase 2

Completed

Conditions: Adrenocortical Carcinoma

Interventions: Drug: cisplatin, taxotere

First Posted Date: 2006-05-10

Last Posted Date: 2012-02-22

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 19

Registration Number: NCT00324012

Locations: 🇩🇰
Department of Oncology 5073, Rigshospitalet, Copenhagen, Denmark

Transfer of Skills From VR-Trainer to Operation Room

Phase 2

Completed

Conditions: Clinical Competence

Interventions: Behavioral: LapSimGyn training until expert proficiency level is reached
Behavioral: Traditional clinical education

First Posted Date: 2006-04-06

Last Posted Date: 2007-08-30

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 24

Registration Number: NCT00311792

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy